Rifampin-containing regimens for community-associated skin infection: a hazard without known benefit

Am J Emerg Med. 2009 Sep;27(7):893-4. doi: 10.1016/j.ajem.2009.01.014.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Infective Agents / administration & dosage
  • Antibiotics, Antitubercular / adverse effects
  • Antibiotics, Antitubercular / therapeutic use*
  • Community-Acquired Infections / drug therapy
  • Drug Therapy, Combination
  • Female
  • Furunculosis / drug therapy*
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Rifampin / adverse effects
  • Rifampin / therapeutic use*
  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage

Substances

  • Anti-Infective Agents
  • Antibiotics, Antitubercular
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Rifampin